N BRERETON MEDICAL TECHNOLOGIES

Lobbying client · Virginia · filed 2025 to 2026

Opiod prevention through a titration-based methodology.

$45,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (68145), not by name.

Firms hired 1

THE CONSILIO GROUP $45,000 5 filings

Reported by year 2 years

2026 $0 1 filing
2025 $45,000 4 filings

Issues lobbied 1

Alcohol and Drug Abuse 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Health & Human Services, Dept of (HHS) 4
HOUSE OF REPRESENTATIVES 4
Natl Institutes of Health (NIH) 4
SENATE 4

Recent filings 5 total

1T

THE CONSILIO GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 15, 2026

View → Q4

THE CONSILIO GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $15,000 income · posted Apr 9, 2026

View → Q3

THE CONSILIO GROUP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $15,000 income · posted Oct 20, 2025

View → Q2

THE CONSILIO GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $15,000 income · posted Jul 23, 2025

View → RR

THE CONSILIO GROUP

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 22, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.